L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
XCp8EdX797HqtKKD
